Treatment of Chronic Bacterial Prostatitis in Chronic Scrotal Content Pain (Unilateral Scrotal Pain)
This protocol covers the management of chronic bacterial prostatitis when the clinical presentation includes chronic scrotal content pain (CSCP) — persistent unilateral scrotal pain that has lasted more than three months and interferes with activities of daily living.
Clinical Scenario
Chronic scrotal content pain is defined as unilateral scrotal pain interfering with activities of daily living that has persisted for greater than three months. The diagnosis is established after excluding other causes, including testicular torsion, epididymitis, orchitis, abscess, testicular mass, and varicocele. Clinicians should consider this diagnosis in patients with isolated unilateral chronic scrotal pain in the absence of other pelvic pain sites or urinary symptoms.
Management Approach
The recommended approach is conservative multimodal therapy, combining lifestyle measures with structured pain management strategies. The complete protocol specifies which interventions are indicated, in what order, and under which clinical circumstances — the full regimen is available via the link below.
Treatment Goals
Reduction in scrotal pain
Improved quality of life
References
DOI: 10.1097/JU.0000000000004564
- CSCP or chronic testicular pain or chronic orchialgia is defined as unilateral scrotal pain interfering with activities of daily living that has persisted for greater than three months of time.
- CSCP is usually diagnosed after excluding other potential causes (e.g., testicular torsion, epididymitis, orchitis, abscess, testicular mass, varicocele).
- Clinicians should consider the diagnosis of CSCP in patients who experienced unilateral chronic scrotal pain in the absence of other pelvic sites of pain or urinary symptoms.
- Clinicians should discuss lifestyle modification that may improve symptoms and implement as feasible.
- In patients with CSCP, clinicians may prescribe pharmacologic pain management agents such as acetaminophen, nonsteroidal anti-inflammatory drugs, tricyclic antidepressants, gabapentinoids, and non-opioid options after counseling patients on the risks and benefits.
- Multimodal therapy to pain management is recommended.
View source ↗